ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival.
BACKGROUND: The oncogenesis of ovarian cancer is poorly understood. The aim of this study was to identify mRNAs differentially expressed between moderately and poorly differentiated (MD/PD) serous ovarian carcinomas (SC), serous ovarian borderline tumours (SBOT) and superficial scrapings from normal...
Main Authors: | Bente Vilming Elgaaen, Ole Kristoffer Olstad, Leiv Sandvik, Elin Odegaard, Torill Sauer, Anne Cathrine Staff, Kaare M Gautvik |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3460818?pdf=render |
Similar Items
-
Correction: and () Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas.
by: Bente Vilming Elgaaen, et al.
Published: (2010-01-01) -
POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas.
by: Bente Vilming Elgaaen, et al.
Published: (2010-11-01) -
Correction: POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas
by: Bente Vilming Elgaaen, et al.
Published: (2010-01-01) -
Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer
by: Ning Yan, et al.
Published: (2021-01-01) -
LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway
by: Wei Li, et al.
Published: (2021-09-01)